These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3374739)

  • 1. Oral tacrine administration in middle-aged monkeys: effects on discrimination learning.
    Fitten LJ; Perryman K; Tachiki K; Kling A
    Neurobiol Aging; 1988; 9(2):221-4. PubMed ID: 3374739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
    Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L
    N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.
    Summers WK; Majovski LV; Marsh GM; Tachiki K; Kling A
    N Engl J Med; 1986 Nov; 315(20):1241-5. PubMed ID: 2430180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term oral administration of memory-enhancing doses of tacrine in mice: a study of potential toxicity and side effects.
    Fitten LJ; Flood JF; Baxter CF; Tachiki KH; Perryman K
    J Gerontol; 1987 Nov; 42(6):681-5. PubMed ID: 3680887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the novel acetylcholinesterase inhibitor N-octyl-1,2,3, 4-tetrahydro-9-aminoacridine on locomotor activity and avoidance learning in mice.
    Capone F; Oliverio A; Pomponi M; Marta M; Gatta F; Pavone F
    Neurobiol Learn Mem; 1999 May; 71(3):301-7. PubMed ID: 10196108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of chronic tacrine therapy on d-tubocurarine blockade in the soleus and tibialis muscles of the rat.
    Ibebunjo C; Donati F; Fox GS; Eshelby D; Tchervenkov JI
    Anesth Analg; 1997 Aug; 85(2):431-6. PubMed ID: 9249126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus properties of NIK-247 and tetrahydroaminoacridine, centrally active cholinesterase inhibitors, in rats.
    Yamamoto T; Ohno M; Sugimachi K; Ueki S
    Pharmacol Biochem Behav; 1993 Apr; 44(4):769-75. PubMed ID: 8469688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divided attention-enhancing effects of AF102B and THA in aging monkeys.
    O'Neill J; Fitten LJ; Siembieda DW; Crawford KC; Halgren E; Fisher A; Refai D
    Psychopharmacology (Berl); 1999 Apr; 143(2):123-30. PubMed ID: 10326774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of THA on hemicholinium-3-induced learning impairment is independent of serotonergic and noradrenergic systems.
    Hagan JJ; Jansen JH; Nefkens FE; de Boer T
    Psychopharmacology (Berl); 1990; 101(3):376-83. PubMed ID: 2362954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine.
    Hartvig P; Askmark H; Aquilonius SM; Wiklund L; Lindström B
    Eur J Clin Pharmacol; 1990; 38(3):259-63. PubMed ID: 2340845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of plasma tacrine concentrations using an in vitro cholinesterase inhibition assay.
    Moriearty PL; Kenny W; Kumar V
    Alzheimer Dis Assoc Disord; 1989; 3(3):143-7. PubMed ID: 2789791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.
    Chatellier G; Lacomblez L
    BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THA increases action potential duration of central histamine neurons in vitro.
    Reiner PB; McGeer EG
    Eur J Pharmacol; 1988 Oct; 155(3):265-70. PubMed ID: 3148476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of tacrine and metabolites in rat brain and plasma after single- and multiple-dose regimens. Evidence for accumulation of tacrine in brain tissue.
    McNally WP; Pool WF; Sinz MW; Dehart P; Ortwine DF; Huang CC; Chang T; Woolf TF
    Drug Metab Dispos; 1996 Jun; 24(6):628-33. PubMed ID: 8781777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of BMY 21502 on acquisition of shape discrimination and memory retention in monkey.
    Fitten LJ; Perryman KM; Hanna JA; Menon MK
    Pharmacol Biochem Behav; 1990 Mar; 35(3):553-6. PubMed ID: 2339147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.
    Almkvist O; Jelic V; Amberla K; Hellström-Lindahl E; Meurling L; Nordberg A
    Dement Geriatr Cogn Disord; 2001; 12(1):22-32. PubMed ID: 11125238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of motoric agitation and restlessness by AF102B and tacrine in the macaque.
    Fitten LJ; Ortiz F; Siembieda DW; O'Neill J; Halgren E; Fisher A
    J Neuropsychiatry Clin Neurosci; 1999; 11(1):79-85. PubMed ID: 9990560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excitatory actions of tetrahydro-9-aminoacridine (THA) on hippocampal pyramidal neurons.
    Stevens DR; Cotman CW
    Neurosci Lett; 1987 Aug; 79(3):301-5. PubMed ID: 3658222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and biochemical assessment of SM-10888, a novel cholinesterase inhibitor.
    Natori K; Okazaki Y; Irie T; Katsube J
    Jpn J Pharmacol; 1990 Jun; 53(2):145-55. PubMed ID: 2385001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cholinergic drugs on learning impairment in ventral globus pallidus-lesioned rats.
    Ueki A; Miyoshi K
    J Neurol Sci; 1989 Mar; 90(1):1-21. PubMed ID: 2723670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.